Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors which are anti-inflammatory when stimulated.
Emerging immunopharmacological targets in multiple sclerosis.
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Interferon-β Modulates Inflammatory Response in Cerebral Ischemia.
MS Trust critical of guidance on multiple sclerosis.
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Natalizumab discontinuation in the increasing complexity of multiple sclerosis therapy.
Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients.
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Possible role of human herpesvirus 6 as a trigger of autoimmune disease.
Systematic imaging review: Multiple Sclerosis.
Proteomic analysis for early neurodegenerative biomarker detection in an animal model.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
What lies beneath grey matter atrophy in multiple sclerosis?
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelization attacks.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Advances in the management of multiple sclerosis spasticity: recent clinical trials.
Remyelination therapy goes to trial for multiple sclerosis.
Diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia due to multiple sclerosis.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »